" class="no-js "lang="en-US"> MIMETAS - Medtech Alert
Sunday, March 03, 2024



MIMETAS (Leiden, The Netherlands) is a global leader in disease modeling using organ-on-a-chip technologies. Its proprietary OrganoPlate® platform enables the development and high-throughput screening of physiologically relevant disease models for drug discovery and development. The company offers its technology and expertise in therapy co-development projects, services, and off-the-shelf products. MIMETAS works with leading pharmaceutical and biotech companies worldwide to develop novel therapies against unsolved diseases. Founded in 2013 in Leiden, the Netherlands, MIMETAS has grown into a multinational company with operations in Europe, Asia, and the USA.

Related Story

MIMETAS and Astellas Enter into Strategic Partnership

March 29 2023

MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]